Skip to main content
2025 DC/CSEM Professional Conference Main banner
On-Demand

Accredited Symposium

AS05 - Transforming Type 1 Diabetes Care: Early Detection Strategies and Therapies to Delay Clinical Onset

Saturday, November 29, 2025
09:15 - 10:30 Toronto
Location: Room 206

    Speaker(s)

  • Peter Lin, MD CCFP (he/him/his)

    Family Physician and Director at the Canadian Heart Research Center
    Canadian Heart Research Center
    Canadian Heart Research Centre
    North York, Ontario, Canada

    Disclosure(s): Abbott Canada: Speaker/Honoraria (Ongoing); Amgen Canada: Speaker/Honoraria (Ongoing); Bayer Canada: Speaker/Honoraria (Ongoing); Boehringer Ingelheim: Speaker/Honoraria (Ongoing); Novo-Nordisk: Speaker/Honoraria (Ongoing); sanofi: Speaker/Honoraria (Ongoing)

  • Peter Senior, MBBS PhD

    MD, PhD
    University of Alberta
    Alberta Diabetes Institute
    Edmonton, Alberta, Canada

    Disclosure information not submitted.

  • Susie Jin, RPh CDE (she/her/hers)

    Pharmacist
    Cobourg, Ontario
    Cobourg, Ontario, Canada

    Disclosure(s): Abbott Diabetes: Advisory Board (Ongoing), Independent Contractor (Ongoing), Speaker/Honoraria (Ongoing); Abbvie: Advisory Board (Terminated, June 21, 2024); Bieiersdorf: Advisory Board (Ongoing); Boehringer Ingelheim: Employment (Terminated, January 10, 2025), Grant/Research Support (Terminated, January 10, 2025); Dexcom Canada: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Diabetes Canada: Independent Contractor (Ongoing), Speaker/Honoraria (Ongoing); Kenvue: Speaker/Honoraria (Terminated, April 5, 2025); Moderna: Committee/Planning Member (Terminated, August 30, 2024), Speaker/Honoraria (Terminated, August 30, 2024); Novo Nordisk Canada: Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing); Ontario Pharmacists Association: Speaker/Honoraria (Ongoing); sanofi aventis: Speaker/Honoraria (Terminated, July 12, 2024); Sol-Millenium: Speaker/Honoraria (Ongoing)

    • Moderator(s)

  • Elizabeth Rosowlowsky, MD, MPH (she/her/hers)

    Pediatric Endocrinologist
    University of Alberta
    University of Alberta
    Edmonton, Alberta, Canada

    Disclosure(s): Abbott Canada: Committee/Planning Member (Terminated), Speaker/Honoraria (Terminated); CIHR: Grant/Research Support (Ongoing); National Institutes of Health/NIDDK: Grant/Research Support (Ongoing); Sanofi Canada: Advisory Board (Ongoing), Committee/Planning Member (Ongoing), Speaker/Honoraria (Ongoing); Tolmar: Advisory Board (Terminated)

Disclosure(s):
Peter Lin: Abbott Canada: Speaker/Honoraria (Ongoing); Amgen Canada: Speaker/Honoraria (Ongoing); Bayer Canada: Speaker/Honoraria (Ongoing); Boehringer Ingelheim: Speaker/Honoraria (Ongoing); Novo-Nordisk: Speaker/Honoraria (Ongoing); sanofi: Speaker/Honoraria (Ongoing)
Susie Jin, RPh CDE: Abbott Diabetes: Advisory Board (Ongoing), Independent Contractor (Ongoing), Speaker/Honoraria (Ongoing); Abbvie: Advisory Board (Terminated, June 21, 2024); Bieiersdorf: Advisory Board (Ongoing); Boehringer Ingelheim: Employment (Terminated, January 10, 2025), Grant/Research Support (Terminated, January 10, 2025); Dexcom Canada: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Diabetes Canada: Independent Contractor (Ongoing), Speaker/Honoraria (Ongoing); Kenvue: Speaker/Honoraria (Terminated, April 5, 2025); Moderna: Committee/Planning Member (Terminated, August 30, 2024), Speaker/Honoraria (Terminated, August 30, 2024); Novo Nordisk Canada: Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing); Ontario Pharmacists Association: Speaker/Honoraria (Ongoing); sanofi aventis: Speaker/Honoraria (Terminated, July 12, 2024); Sol-Millenium: Speaker/Honoraria (Ongoing)
Elizabeth Rosowlowsky, MD, MPH: Abbott Canada: Committee/Planning Member (Terminated), Speaker/Honoraria (Terminated); CIHR: Grant/Research Support (Ongoing); National Institutes of Health/NIDDK: Grant/Research Support (Ongoing); Sanofi Canada: Advisory Board (Ongoing), Committee/Planning Member (Ongoing), Speaker/Honoraria (Ongoing); Tolmar: Advisory Board (Terminated)

Learning Objectives:

  • Review the epidemiology, staging, and clinical landscape of autoimmune T1D
  • Devise strategies and early detection protocols to assess the risk of developing autoimmune T1D and prevent complications such as DKA
  • Explore treatment options to delay the onset and progression of autoimmune T1D